Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALNY
DXCM
Add up to 3 more stocks
ALNY
Alnylam Pharmaceuticals, Inc.
+0.23%
$237.10+0.54At close: Aug 28, 2026, 4:00 PM ET
Market Cap
$31.73B
52W Range
$197.81 - $495.55
DXCM
DexCom, Inc.
+1.71%
$90.82+1.53At close: Aug 28, 2026, 4:00 PM ET
Market Cap
$34.27B
52W Range
$54.11 - $92.59
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 40.05 | 35.90 |
| Forward P/E | 36.43 | 34.05 |
| P/B Ratio | 24.21 | 13.57 |
| P/S Ratio | 6.82 | 7.16 |
| P/FCF Ratio | 60.42 | 25.33 |
| EV/EBITDA | 30.68 | 25.57 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 79.7% | 62.5% |
| Operating Margin | 20.8% | 22.9% |
| Net Margin | 16.8% | 20.1% |
| ROE | 59.7% | 38.1% |
| ROA | 14.5% | 15.5% |
| ROIC | 24.7% | 21.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.05 | 1.73 |
| Quick Ratio | 2.99 | 1.43 |
| Debt/Equity | 0.94 | 0.53 |
| Interest Coverage | 1.99 | 49.83 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.